Tested Applications
Positive WB detected in | mouse small intestine tissue, rat small intestine tissue |
Recommended dilution
Application | Dilution |
---|---|
Western Blot (WB) | WB : 1:1000-1:6000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
85955-1-RR targets Annexin A13 in WB, ELISA applications and shows reactivity with human samples.
Tested Reactivity | human |
Host / Isotype | Rabbit / IgG |
Class | Recombinant |
Type | Antibody |
Immunogen | Annexin A13 fusion protein Ag18581 Predict reactive species |
Full Name | annexin A13 |
Calculated Molecular Weight | 316 aa, 35 kDa |
Observed Molecular Weight | 35 kDa |
GenBank Accession Number | BC125158 |
Gene Symbol | Annexin A13 |
Gene ID (NCBI) | 312 |
Conjugate | Unconjugated |
Form | Liquid |
Purification Method | Protein A purification |
UNIPROT ID | P27216 |
Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Annexin A13 (ANXA13) is believed to be the original founder gene of the 12-member vertebrate annexin A family, and it has acquired an intestine-specific expression associated with a highly differentiated intracellular transport function (PMID: 11961095). ANXA13, which is highly expressed in the digestive system and believed to be the original founder gene of the annexin A family (PMID: 28423508). Limited evidence suggests that ANXA13 may play a role in apoptotic cell-mediated immunosuppression, hypertension, and cell death recognition (PMID: 28423508). ANXA13 is highly expressed in the human colon adenocarcinoma cell line HT29.
Protocols
Product Specific Protocols | |
---|---|
WB protocol for Annexin A13 antibody 85955-1-RR | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |